Survival or death: Disequilibrating the oncogenic and tumor suppressive autophagy in cancer

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Liu, B ^a   Wen, X ^a   Cheng, Y ^b  

^a SICHUAN UNIVERSITY   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Autophagy; Cancer; MicroRNA; Oncogene; Tumor suppressor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; AMIODARONE; AZD 8055; BECLIN 1; CHLOROQUINE; CISPLATIN; DASATINIB; ERLOTINIB; EVEROLIMUS; GEFITINIB; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; MICRORNA; NICLOSAMIDE; PACLITAXEL; PERHEXILINE; RAPAMYCIN; RIDAFOROLIMUS; SEOCALCITOL; SULFACETAMIDE; SULFATHIAZOLE; TAMOXIFEN; TEMSIROLIMUS; TETRAHYDROCANNABINOL; WORTMANNIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; BREAST CARCINOMA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CANCER STEM CELL; CELL DEATH; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CHRONIC LYMPHATIC LEUKEMIA; COLON ADENOCARCINOMA; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; NONSENSE MUTATION; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; STOMACH CARCINOMA; TUMOR INVASION;

ANIMALS; AUTOPHAGY; HUMANS; MICRORNAS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84887486465     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.422     Document Type: Review

References (110)

1. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368: 651-662
2. Yang Z, Klionsky DJ. Eaten alive: A history of macroautophagy. Nat Cell Biol 2010; 12: 814-822
3. Oczypok EA, Oury TD, Chu CT. It's a cell-eat-cell world: Autophagy and phagocytosis. Am J Pathol 2013; 182: 612-622
4. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20: 1992-2003
5. Yang Z, Klionsky DJ. Mammalian autophagy: Core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22: 124-131
6. Fu LL, Cheng Y, Liu B. Beclin-1: Autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol 2013; 45: 921-924
7. Ravikumar B, Moreau K, Jahreiss L, Puri C, Rubinsztein DC. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat Cell Biol 2010; 12: 747-757
8. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011; 17: 654-666
9. Meschini S, Condello M, Lista P, Arancia G. Autophagy: Molecular mechanisms and their implications for anticancer therapies. Curr Cancer Drug Targets 2011; 11: 357-379
10. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC et al. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 2009; 1793: 1524-1532
11. Kroemer G, Levine B. Autophagic cell death: The story of a misnomer. Nat Rev Mol Cell Biol 2008; 9: 1004-1010
12. Maiese K, Chong ZZ, Shang YC, Wang S. Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets 2012; 16: 1203-1214
13. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120
14. Clarke PG, Puyal J. Autophagic cell death exists. Autophagy 2012; 8: 867-869
15. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42
16. Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS et al. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011; 32: 964-972
17. Song YJ, Zhang SS, Guo XL, Sun K, Han ZP, Li R et al. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett 2013; 339: 70-81
18. Singh BN, Kumar D, Shankar S, Srivastava RK. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol 2012; 84: 1154-1163
19. Chaterjee M, van Golen KL. Breast cancer stem cells survive periods of farnesyltransferase inhibitor-induced dormancy by undergoing autophagy. Bone Marrow Res 2011; 2011: 362938
20. Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A et al. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013; 32: 699-712
21. Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, Kalkanis SN et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer 2009; 125: 717-722
22. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674
23. Zhou J, Tan SH, Codogno P, Shen HM. Dual suppressive effect of MTORC1 on autophagy: Tame the dragon by shackling both the head and the tail. Autophagy 2013; 9: 803-805
24. Zhang Y, Gan B, Liu D, Paik JH. FoxO family members in cancer. Cancer Biol Ther 2011; 12: 253-259
25. Altman BJ, Jacobs SR, Mason EF, Michalek RD, MacIntyre AN, Coloff JL et al. Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 2011; 30: 1855-1867
26. Elgendy M, Sheridan C, Brumatti G, Martin SJ. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 2011; 42: 23-35
27. Xie X, Le L, Fan Y, Lv L, Zhang J. Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition. Autophagy 2013; 8: 1071-1084
28. Kenzelmann Broz D, Spano Mello S, Bieging KT, Jiang D, Dusek RL, Brady CA et al. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 2013; 27: 1016-1031
29. Beleva E, Grudeva-Popova J. From Virchow's triad to metastasis: Circulating hemostatic factors as predictors of risk for metastasis in solid tumors. J BUON 2013; 18: 25-33
30. Avivar-Valderas A, Bobrovnikova-Marjon E, Alan Diehl J, Bardeesy N, Debnath J, Aguirre-Ghiso JA. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 2013; 32: 4932-4940
31. Kenific CM, Thorburn A, Debnath J. Autophagy and metastasis: Another double-edged sword. Curr Opin Cell Biol 2010; 22: 241-245
32. Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I et al. Warburg meets autophagy: Cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 2012; 16: 1264-1284
33. Zhang J, Yang Z, Xie L, Xu L, Xu D, Statins Liu X. Autophagy and cancer metastasis. Int J Biochem Cell Biol 2013; 45: 745-752
34. Sosa MS, Bragado P, Debnath J, Aguirre-Ghiso JA. Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv Exp Med Biol 2013; 734: 73-89
35. Lu Z, Bast RC Jr. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Cell Adh Migr 2013; 7: 232-236
36. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118: 3917-3929
37. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9: 218-224
38. Liu JJ, Lin M, Yu JY, Liu B, Bao JK. Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 2011; 300: 105-114
39. Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012; 11: 709-730
40. Jewell JL, Russell RC, Guan KL. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 2013; 14: 133-139
41. Morselli E, Galluzzi L, Kepp O, Mariño G, Michaud M, Vitale I et al. Oncosuppressive functions of autophagy. Antioxid Redox Signal 2011; 14: 2251-2269
42. Vadlakonda L, Pasupuleti M, Pallu R. Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells. Front Oncol 2013; 3: 85
43. Beauchamp EM, Platanias LC. The evolution of the TOR pathway and its role in cancer. Oncogene 2012; 32: 3923-3932
44. Russell RC, Tian Y, Yuan H, Park HW, Chang YY, Kim J et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 2013; 15: 741-750
45. Calabretta B, Salomoni P. Suppression of autophagy by BCR/ABL. Front Biosci (Schol Ed) 2012; 4: 453-460
46. Wu SY, Lan SH, Cheng DE, Chen WK, Shen CH, Lee YR et al. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation. Neoplasia 2011; 13: 1171-1182
47. Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res 2011; 71: 5976-5986
48. Huang W, Choi W, Hu W, Mi N, Guo Q, Ma M et al. Crystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding protein. Cell Res 2012; 22: 473-489
49. Zhang X, Chen LX, Ouyang L, Cheng Y, Liu B. Plant natural compounds: Targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif 2012; 45: 466-476
50. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B et al. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45: 487-498
51. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18: 571-580
52. Song X, Zhang X, Wang X, Zhu F, Guo C, Wang Q. Tumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5. Autophagy 2013; 9: 743-755
53. Napoli M, Flores ER. The family that eats together stays together: New p53 family transcriptional targets in autophagy. Genes Dev 2013; 27: 971-974
54. Morselli E, Galluzzi L, Kroemer G. Mechanisms of p53-mediated mitochondrial membrane permeabilization. Cell Res 2008; 18: 708-710
55. Brady CA, Attardi LD. p53 at a glance. J Cell Sci 2010; 123: 2527-2532
56. Medema RH, Jää ttelä M. Cytosolic FoxO1: Alive and killing. Nat Cell Biol 2010; 12: 642-643
57. Zhao Y, Li X, Cai MY, Ma K, Yang J, Zhou J et al. XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cells. Cell Res 2013; 23: 491-507
58. Frankel LB, Lund AH. MicroRNA regulation of autophagy. Carcinogenesis 2012; 33: 2018-2025
59. Qased AB, Yi H, Liang N, Ma S, Qiao S, Liu X. MicroRNA-18a upregulates autophagy and ataxia telangiectasia mutated gene expression in HCT116 colon cancer cells. Mol Med Rep 2013; 7: 559-564
60. Tekirdag KA, Korkmaz G, Ozturk DG, Agami R, Gozuacik D. MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5. Autophagy 2013; 9: 374-385
61. Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F et al. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem Biophys Res Commun 2012; 423: 826-831
62. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008; 283: 29897-29903
63. Korkmaz G, le Sage C, Tekirdag KA, Agami R, Gozuacik D. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy 2012; 8: 165-176
64. Comincini S, Allavena G, Palumbo S, Morini M, Durando F, Angeletti F et al. microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. Cancer Biol Ther 2013; 14: 574-586
65. Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L et al. MicroRNA 23b Regulates autophagy Associated with radioresistance of Pancreatic Cancer Cells. Gastroenterology 2013; doi:10.1053/j.gastro.2013.07.048
66. Zou Z, Wu L, Ding H, Wang Y, Zhang Y, Chen X et al. MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J Biol Chem 2012; 287: 4148-4156
67. Xu Y, An Y, Wang Y, Zhang C, Zhang H, Huang C et al. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep 2013; 29: 2019-2024
68. Frankel LB, Wen J, Lees M, Høyer-Hansen M, Farkas T, Krogh A et al. microRNA-101 is a potent inhibitor of autophagy. EMBO J 2011; 30: 4628-4641
69. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012; 72: 1763-1772
70. Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012; 21: 532-546
71. Xiao J, Zhu X, He B, Zhang Y, Kang B, Wang Z et al. MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II. J Biomed Sci 2011; 18: 35
72. Chang Y, Yan W, He X, Zhang L, Li C, Huang H et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012; 1: 177-187
73. Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: A new generation of mTOR inhibitors. Nat Rev Drug Discovery 2011; 10: 868-880
74. Martin LA, André F, Campone M, Bachelot T, Jerusalem G. mTOR inhibitors in advanced breast cancer: Ready for prime time? Cancer Treat Rev 2013; 39: 742-752
75. Chen T, Shen L, Yu J, Wan H, Guo A, Chen J et al. Rapamycin and other longevitypromoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 2011; 10: 908-911
76. Liu Q, Thoreen C, Wang J, Sabatini D, Gray NS. mTOR mediated anti-cancer drug discovery. Drug Discov Today Ther Strateg 2009; 6: 47-55
77. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG et al. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 2009; 4: E7124
78. Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T et al. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer 2012; 131: 548-557
79. Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 2010; 70: 288-298
80. Gurpinar E, Grizzle WE, Shacka JJ, Mader BJ, Li N, Piazza NA et al. A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy. Mol Cancer Ther 2013; 12: 663-674
81. Evangelisti C, Ricci F, Tazzari P, Chiarini F, Battistelli M, Falcieri E et al. Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia. J Cell Physiol 2011; 226: 822-831
82. Bommareddy A, Hahm ER, Xiao D, Powolny AA, Fisher AL, Jiang Y et al. ATG5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 2009; 69: 3704-3712
83. Vara D, Morell C, Rodríguez-Henche N, Diaz-Laviada I. Involvement of PPARg in the antitumoral action of cannabinoids on hepatocellular carcinoma. Cell Death Dis 2013; 4: E618
84. Brüning A, Rahmeh M, Friese K. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation. Mol Oncol 2013 pii S1574-7891: 00107-5
85. Fu L, Kim YA, Wang X, Wu X, Yue P, Lonial S et al. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res 2009; 69: 8967-8976
86. Liu TJ, Koul D, LaFortune T, Tiao N, Shen RJ, Maira SM et al. NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Mol Cancer Ther 2009; 8: 2204-2210
87. Fan QW, Weiss WA. Inhibition of PI3K-Akt-mTOR signaling in glioblastoma by mTORC1/2 inhibitors. Methods Mol Biol 2012; 821: 349-359
88. Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I et al. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 2011; 7: 176-187
89. Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF et al. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med 2012; 52: 377-391
90. Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008; 15: 1318-1329
91. Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 2009; 16: 1018-1029
92. Chen M, Du Y, Qui M, Wang M, Chen K, Huang Z et al. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Rep 2013; 29: 430-436
93. El-Metnawy WH, Mattar MM, El-Nahass YH, Samra MA, Abdelhamid HM, Abdlfattah RM et al. Predictive value of pretreatment BCR-ABL(IS) transcript level on response to imatinib therapy in Egyptian patients with Chronic Phase Chronic Myeloid Leukemia (CPCML). Int J Biomed Sci 2013; 9: 48-53
94. Schafranek L, Leclercq TM, White DL, Hughes TP. Clarithromycin enhances dasatinibinduced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy. Leuk Lymphoma 2013; 54: 198-201
95. HanW, Pan H, Chen Y, Sun J, Wang Y, Li J et al. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One 2011; 6: E18691
96. Huang HL, Chen YC, Huang YC, Yang KC, Hy Pan, Shih SP et al. Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells. PLoS One 2011; 6: E29014
97. John S, Nayvelt I, Hsu HC, Yang P, Liu W, Das GM et al. Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Res 2008; 68: 7855-7863
98. Malik SA, Orhon I, Morselli E, Criollo A, Shen S, Mariño G et al. BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 2011; 30: 918-929
99. Høyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jää ttelä M. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ 2005; 12: 1297-1309
100. Wang H, Yu J, Li Y, Hao Y, Choi A, Ke H et al. Beclin 1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011; 147: 223-234
101. Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L et al. The inositol 1,4,5- trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ 2009; 16: 1006-1017
102. Crazzolara R, Bradstock KF, Bendall LJ. RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia. Autophagy 2009; 5: 727-728
103. Xia YH, Cheng CR, Yao SY, Zhang Q, Wang Y, Ji ZN. L-securinine induced the human colon cancer SW480 cell autophagy and its molecular mechanism. Fitoterapia 2011; 82: 1258-1264
104. Wu Y, Wang X, Guo H, Zhang B, Zhang XB, Shi ZJ et al. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy 2013; 9: 595-603
105. Baek KH, Park J, Shin I. Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev 2012; 41: 3245-3263
106. Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011; 8: 528-539
107. Hayashi S, Yamamoto A, You F, Yamashita K, Ikegame Y, Tawada M et al. The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol 2009; 175: 2226-2234
108. Choudhury S, Kolukula VK, Preet A, Albanese C, Avantaggiati ML. Dissecting the pathways that destabilize mutant p53: The proteasome or autophagy? Cell Cycle 2013; 12: 1022-1029
109. Mohammadpour R, Safarian S, Sheibani N, Norouzi S, Razazan A. Death inducing and cytoprotective autophagy in T-47D cells by two common antibacterial drugs: Sulphathiazole and sulphacetamide. Cell Biol Int 2013; 24: 348-358
110. Von Clausewitz C. Vom Kriege (On War). Dümmlers Verlag, Berlin 1832